Dipiaron Overview

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 1

Dipiaron General Information

Description

Developer of an oral drug designed to help doctors treat type 2 diabetes mellitus, metabolic syndrome, and obesity. The company's drug is a GPR119 receptor agonist that stimulates the secretion of incretins and insulin, enabling type 2 diabetes patients to have an effective and safe treatment option that reduces the risk of complications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Ter Skolkovo Innovation Center
  • Bolshoy b-r, 42 p. 1
  • Moscow, 121205
  • Russia
+7 8
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Ter Skolkovo Innovation Center
  • Bolshoy b-r, 42 p. 1
  • Moscow, 121205
  • Russia
+7 8

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dipiaron Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 28-Sep-2022 Completed Clinical Trials - Phase 1
To view Dipiaron’s complete valuation and funding history, request access »

Dipiaron Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Unicorn Capital Partners Venture Capital Minority
To view Dipiaron’s complete investors history, request access »

Dipiaron FAQs

  • Where is Dipiaron headquartered?

    Dipiaron is headquartered in Moscow, Russia.

  • What industry is Dipiaron in?

    Dipiaron’s primary industry is Drug Discovery.

  • Is Dipiaron a private or public company?

    Dipiaron is a Private company.

  • What is Dipiaron’s current revenue?

    The current revenue for Dipiaron is .

  • Who are Dipiaron’s investors?

    Unicorn Capital Partners has invested in Dipiaron.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process